Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ascendis Pharma A (ASND) Total Current Liabilities: 2012-2025

Historic Total Current Liabilities for Ascendis Pharma A (ASND) over the last 10 years, with Sep 2025 value amounting to $1.2 billion.

  • Ascendis Pharma A's Total Current Liabilities rose 25.24% to $1.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 billion, marking a year-over-year increase of 25.24%. This contributed to the annual value of $982.6 million for FY2024, which is 24.00% up from last year.
  • Latest data reveals that Ascendis Pharma A reported Total Current Liabilities of $1.2 billion as of Q3 2025, which was up 8.96% from $1.1 billion recorded in Q2 2025.
  • Over the past 5 years, Ascendis Pharma A's Total Current Liabilities peaked at $1.2 billion during Q3 2025, and registered a low of $84.7 million during Q2 2021.
  • In the last 3 years, Ascendis Pharma A's Total Current Liabilities had a median value of $912.9 million in 2024 and averaged $751.0 million.
  • Data for Ascendis Pharma A's Total Current Liabilities shows a peak YoY soared of 353.50% (in 2023) over the last 5 years.
  • Ascendis Pharma A's Total Current Liabilities (Quarterly) stood at $114.8 million in 2021, then spiked by 52.21% to $174.7 million in 2022, then skyrocketed by 353.50% to $792.4 million in 2023, then grew by 22.42% to $970.1 million in 2024, then rose by 25.24% to $1.2 billion in 2025.
  • Its Total Current Liabilities was $1.2 billion in Q3 2025, compared to $1.1 billion in Q2 2025 and $931.5 million in Q1 2025.